These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 15699119

  • 1. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI, Ogasawara K, Hamerman JA, Takaki R, Zingoni A, Allison JP, Lanier LL.
    J Immunol; 2005 Feb 15; 174(4):1922-31. PubMed ID: 15699119
    [Abstract] [Full Text] [Related]

  • 2. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.
    Markiewicz MA, Carayannopoulos LN, Naidenko OV, Matsui K, Burack WR, Wise EL, Fremont DH, Allen PM, Yokoyama WM, Colonna M, Shaw AS.
    J Immunol; 2005 Sep 01; 175(5):2825-33. PubMed ID: 16116168
    [Abstract] [Full Text] [Related]

  • 3. Activation of V gamma 9V delta 2 T cells by NKG2D.
    Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T.
    J Immunol; 2005 Aug 15; 175(4):2144-51. PubMed ID: 16081780
    [Abstract] [Full Text] [Related]

  • 4. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
    Whitman E, Barber A.
    Mol Immunol; 2015 Feb 15; 63(2):268-78. PubMed ID: 25089028
    [Abstract] [Full Text] [Related]

  • 5. Costimulation of multiple NK cell activation receptors by NKG2D.
    Ho EL, Carayannopoulos LN, Poursine-Laurent J, Kinder J, Plougastel B, Smith HR, Yokoyama WM.
    J Immunol; 2002 Oct 01; 169(7):3667-75. PubMed ID: 12244159
    [Abstract] [Full Text] [Related]

  • 6. NKG2D is a costimulatory receptor for human naive CD8+ T cells.
    Maasho K, Opoku-Anane J, Marusina AI, Coligan JE, Borrego F.
    J Immunol; 2005 Apr 15; 174(8):4480-4. PubMed ID: 15814668
    [Abstract] [Full Text] [Related]

  • 7. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.
    Alves NL, Arosa FA, van Lier RA.
    J Immunol; 2005 Jul 15; 175(2):755-62. PubMed ID: 16002671
    [Abstract] [Full Text] [Related]

  • 8. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
    Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH.
    Immunity; 2002 Jul 15; 17(1):19-29. PubMed ID: 12150888
    [Abstract] [Full Text] [Related]

  • 9. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A.
    J Immunol; 2005 Jul 15; 175(2):720-9. PubMed ID: 16002667
    [Abstract] [Full Text] [Related]

  • 10. Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells.
    Conejo-Garcia JR, Benencia F, Courreges MC, Gimotty PA, Khang E, Buckanovich RJ, Frauwirth KA, Zhang L, Katsaros D, Thompson CB, Levine B, Coukos G.
    Cancer Res; 2004 Mar 15; 64(6):2175-82. PubMed ID: 15026360
    [Abstract] [Full Text] [Related]

  • 11. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H, Snyder KM, Suhoski MM, Maus MV, Kapoor V, June CH, Mackall CL.
    J Immunol; 2007 Oct 01; 179(7):4910-8. PubMed ID: 17878391
    [Abstract] [Full Text] [Related]

  • 12. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H, Okumura K, Watts TH.
    J Immunol; 2001 Aug 01; 167(3):1313-24. PubMed ID: 11466348
    [Abstract] [Full Text] [Related]

  • 13. NKG2D- and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASp.
    Serrano-Pertierra E, Cernuda-Morollón E, López-Larrea C.
    J Leukoc Biol; 2014 Mar 01; 95(3):487-95. PubMed ID: 24168855
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.
    Dandekar AA, O'Malley K, Perlman S.
    J Virol; 2005 Aug 01; 79(15):9388-96. PubMed ID: 16014902
    [Abstract] [Full Text] [Related]

  • 16. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG, Vendetti S, Bartok I, Schoendorf D, Takacs K, Elliott J, Lechler R, Dyson J.
    J Immunol; 1999 Aug 01; 163(3):1298-305. PubMed ID: 10415027
    [Abstract] [Full Text] [Related]

  • 17. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.
    Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T.
    Nat Immunol; 2001 Mar 01; 2(3):255-60. PubMed ID: 11224526
    [Abstract] [Full Text] [Related]

  • 18. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
    Wang B, Maile R, Greenwood R, Collins EJ, Frelinger JA.
    J Immunol; 2000 Feb 01; 164(3):1216-22. PubMed ID: 10640733
    [Abstract] [Full Text] [Related]

  • 19. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW, Kershaw MH, Hayakawa Y, Cerutti L, Jane SM, Darcy PK, Smyth MJ.
    J Biol Chem; 2005 Nov 18; 280(46):38235-41. PubMed ID: 16169855
    [Abstract] [Full Text] [Related]

  • 20. NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
    Maccalli C, Pende D, Castelli C, Mingari MC, Robbins PF, Parmiani G.
    Eur J Immunol; 2003 Jul 18; 33(7):2033-43. PubMed ID: 12884870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.